271 related articles for article (PubMed ID: 25874546)
1. Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.
Forsblom E; Ruotsalainen E; Järvinen A
PLoS One; 2015; 10(4):e0122824. PubMed ID: 25874546
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
[TBL] [Abstract][Full Text] [Related]
3. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.
Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
J Antimicrob Chemother; 2015 May; 70(5):1539-46. PubMed ID: 25614044
[TBL] [Abstract][Full Text] [Related]
5. Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia-a post hoc analysis in 964 prospectively evaluated patients.
Rieg S; Joost I; Weiß V; Peyerl-Hoffmann G; Schneider C; Hellmich M; Seifert H; Kern WV; Kaasch A
Clin Microbiol Infect; 2017 Jun; 23(6):406.e1-406.e8. PubMed ID: 27615722
[TBL] [Abstract][Full Text] [Related]
6. Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study.
Forsblom E; Kakriainen A; Ruotsalainen E; Järvinen A
Infection; 2018 Dec; 46(6):837-845. PubMed ID: 30194636
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.
Thwaites G; Auckland C; Barlow G; Cunningham R; Davies G; Edgeworth J; Greig J; Hopkins S; Jeyaratnam D; Jenkins N; Llewelyn M; Meisner S; Nsutebu E; Planche T; Read RC; Scarborough M; Soares M; Tilley R; Török ME; Williams J; Wilson P; Wyllie S; Walker AS;
Trials; 2012 Dec; 13():241. PubMed ID: 23249501
[TBL] [Abstract][Full Text] [Related]
8. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
9. Comparable Effectiveness of First Week Treatment with Anti-Staphylococcal Penicillin versus Cephalosporin in Methicillin-Sensitive Staphylococcus aureus Bacteremia: A Propensity-Score Adjusted Retrospective Study.
Forsblom E; Ruotsalainen E; Järvinen A
PLoS One; 2016; 11(11):e0167112. PubMed ID: 27898714
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis.
Ma H; Cheng J; Peng L; Gao Y; Zhang G; Luo Z
PLoS One; 2020; 15(3):e0230383. PubMed ID: 32191760
[TBL] [Abstract][Full Text] [Related]
11. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
[TBL] [Abstract][Full Text] [Related]
12. Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: Observational analyses within the ARREST trial.
Szubert A; Bailey SL; Cooke GS; Peto T; Llewelyn MJ; Edgeworth JD; Walker AS; Thwaites GE;
J Infect; 2019 Oct; 79(4):332-340. PubMed ID: 31398375
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
Trials; 2018 May; 19(1):297. PubMed ID: 29843781
[TBL] [Abstract][Full Text] [Related]
14. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive rifampicin may improve outcomes in Staphylococcus aureus bacteraemia: a systematic review.
Russell CD; Lawson McLean A; Saunders C; Laurenson IF
J Med Microbiol; 2014 Jun; 63(Pt 6):841-848. PubMed ID: 24623637
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
17. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR
Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804
[No Abstract] [Full Text] [Related]
18. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
Parta M; Goebel M; Thomas J; Matloobi M; Stager C; Musher DM
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1043-8. PubMed ID: 20731594
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytopaenia during methicillin-sensitive Staphylococcus aureus bacteraemia.
Forsblom E; Tielinen I; Ruotsalainen E; Järvinen A
Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):887-896. PubMed ID: 28012099
[TBL] [Abstract][Full Text] [Related]
20. Should all adjunctive corticosteroid therapy be avoided in the management of hemodynamically stabile Staphylococcus aureus bacteremia?
Forsblom E; Nurmi AM; Ruotsalainen E; Järvinen A
Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):471-9. PubMed ID: 26768583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
